Oncology Medications Policy

Covers FDA‑approved drugs for direct cancer treatment and oncology medications recommended by NCCN (Categories 1/2A/2B), plus specified FDA‑approved supportive‑care drug classes; excludes non‑cancer uses, medications related to hematopoietic stem cell transplantation, and supportive uses not in the listed classes. Key requirements: prior authorization is required for all covered drugs unless explicitly exempted, with clinical documentation demonstrating alignment with NCCN guidance or FDA indications and additional evidence for exceptions; payer‑specific limits may apply.

"All medications approved by the United States Food & Drug Administration (FDA) and used for the direct treatment of cancer."

Sign up to see full coverage criteria, indications, and limitations.